FDA approves Amjevita, a biosimilar to Humira - FDA Press Releases

The U.S. Food and Drug Administration today approved Amjevita (adalimumab-atto) as a biosimilar to Humira (adalimumab) for multiple inflammatory diseases.

from Food and Drug Administration--Press Releases http://ift.tt/2d4wgwN
via IFTTT